Immunomic

Immunomic is a private clinical-stage biotechnology company dedicated to researching the universal intracellular targeting expression (UNITE) nucleic acid immunotherapy platform. This research technology has the potential to transform the way people use immunotherapy to treat various diseases, including cancer, allergies, and infectious diseases.